Login
$RERE
$3.99 +$0.05 (1.27%) Close

$RERE SEC Filings

Filed On Filing
20 Aug 2026 Form 4: Chen Chen, Director

Granted 91,643 Options (Right to Buy)

20 Aug 2026 Form 4: Wang Yongliang, Director

Granted 159,046 Options (Right to Buy)

20 Aug 2026 6-K
23 Jun 2026 Form 4: Wang Jingbo, Director

Received 15,000 shares by exercise or conversion

11 Jun 2026 Form 4: Zhu Rui, Director

Received 15,000 shares by exercise or conversion · Sold 4,762 shares ($19K)

19 May 2026 6-K
08 Apr 2026 20-F
26 Mar 2026 Form 4: Chen Kerry Xuefeng, Director

Received 8,423,097 shares by exercise or conversion

26 Mar 2026 Form 4: Wang Jingbo, Director

Received 53,250 shares by exercise or conversion

26 Mar 2026 Form 4: Zhu Rui, Director

Received 45,000 shares by exercise or conversion

18 Mar 2026 Form 3: Teng Yue, Director

No securities owned

18 Mar 2026 Form 3: Wang Yongliang, Director
18 Mar 2026 Form 3: Chen Chen, Director

Holds 34,174 shares of American depositary shares

18 Mar 2026 Form 3: Chen Kerry Xuefeng, Director

Holds 11,287,336 shares of Class C ordinary shares

18 Mar 2026 Form 3: Wang Jingbo, Director
18 Mar 2026 Form 3: Zhu Rui, Director
17 Mar 2026 Form 3: Jiang Guoxing, Director

No securities owned

17 Mar 2026 Form 3: Wu Shuangxi, Director

No securities owned

11 Mar 2026 6-K
06 Mar 2026 6-K

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support